Biology Open (BiO) is an online author-pays Open Access journal that publishes peer-reviewed original research in all areas of the biological and biomedical sciences. It is a requirement for consideration at BiO that the work addresses a clearly stated, non-trivial, biological hypothesis. Editors will also consider Methods & Techniques papers, papers on computational analysis, replication studies, and rigorous reports presenting negative results. It is published by The Company of Biologists, a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community.BiO does not consider articles in pure physics, chemistry, engineering, earth sciences, clinical studies, surgical procedures, public health, and homeopathy, complementary or alternative medicine.Since its launch in 2011, BiO has published more than 1100 peer-reviewed papers that have been accepted on the basis that they are technically sound and their conclusions are supported by the data shown – rather than on the perceived importance of the findings. The scope of BiO reflects The Company of Biologists' acknowledged expertise in cell, developmental, experimental and translational biology, and reaches further to support research communities across all aspects of the biological and biomedical sciences. Authors are encouraged to submit their work directly to BiO for consideration by an international board of research-active academic Editors led by Editor-in-Chief Steven Kelly, and Deputy Editors Jack Hayes, Cathy Jackson and Yishi Jin.BiO also extends the service delivered by our sister journals – Development, Journal of Cell Science, Journal of Experimental Biology and Disease Models & Mechanisms. Papers rejected from these journals can be transferred to BiO, strictly with the authors' approval, via a simple one-click manuscript transfer option. We believe this helps the author community by providing a welcoming home for their papers and helping to avoid additional rounds of formatting, submission and review.

生物開放(BiO)是一個在線作者付費開放獲取期刊，發表在生物和生物醫學科學的所有領域的同行評審的原始研究。這是一個需要考慮的要求，在生物的工作，以明確闡述，非平凡，生物學的假設。編輯還將考慮方法和技術論文，關于計算分析的論文，復制研究，以及呈現負面結果的嚴謹報告。它是由生物學家公司出版的，這是一個非盈利的出版組織，致力于支持和激勵生物群落。BiO不考慮純物理、化學、工程、地球科學、臨床研究、外科手術、公共衛生和順勢療法、補充或替代醫學的文章。自2011年推出以來，BiO已經發表了1100多篇同行評議的論文，這些論文之所以被接受，是因為它們在技術上是可靠的，而且它們的結論得到了數據的支持，而不是因為這些發現的重要性。BiO的范圍反映了生物學家在細胞、發育、實驗和轉化生物學方面公認的專業知識，并進一步支持生物和生物醫學科學各方面的研究團體。作者們被鼓勵將他們的作品直接提交BiO，以供由主編史蒂文?凱利(Steven Kelly)、副主編杰克?海耶斯(Jack Hayes)、凱茜?杰克遜(Cathy Jackson)和金一石(Yishi Jin)領導的國際學術研究編輯委員會審議。BiO還擴展了我們的姐妹期刊《發展》、《細胞科學》、《實驗生物學》和《疾病模型與機制》提供的服務。從這些期刊中被拒絕的論文可以通過一個簡單的一鍵式的稿件轉移選項，嚴格按照作者的批準，轉移到BiO。我們相信，這有助于作者社區為他們的論文提供一個歡迎的家，并幫助避免額外的格式化、提交和審查。